US Bancorp’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $141K | Buy |
4,904
+171
| +4% | +$4.92K | ﹤0.01% | 2242 |
|
|
2025
Q1 | $159K | Sell |
4,733
-1,579
| -25% | -$53K | ﹤0.01% | 2139 |
|
|
2024
Q4 | $323K | Sell |
6,312
-5,176
| -45% | -$265K | ﹤0.01% | 1748 |
|
|
2024
Q3 | $587K | Buy |
11,488
+373
| +3% | +$19.1K | ﹤0.01% | 1421 |
|
|
2024
Q2 | $498K | Buy |
11,115
+6,952
| +167% | +$311K | ﹤0.01% | 1493 |
|
|
2024
Q1 | $195K | Buy |
4,163
+3,958
| +1,931% | +$185K | ﹤0.01% | 2022 |
|
|
2023
Q4 | $7.29K | Sell |
205
-8,786
| -98% | -$313K | ﹤0.01% | 3409 |
|
|
2023
Q3 | $267K | Buy |
8,991
+8,928
| +14,171% | +$266K | ﹤0.01% | 1700 |
|
|
2023
Q2 | $1.14K | Sell |
63
-87
| -58% | -$1.57K | ﹤0.01% | 3759 |
|
|
2023
Q1 | $2.41K | Buy |
150
+87
| +138% | +$1.4K | ﹤0.01% | 3694 |
|
|
2022
Q4 | $1.15K | Sell |
63
-18
| -22% | -$329 | ﹤0.01% | 3872 |
|
|
2022
Q3 | $2K | Buy |
81
+18
| +29% | +$444 | ﹤0.01% | 3786 |
|
|
2022
Q2 | $1K | Hold |
63
| – | – | ﹤0.01% | 3909 |
|
|
2022
Q1 | $1K | Hold |
63
| – | – | ﹤0.01% | 3896 |
|
|
2021
Q4 | $2K | Hold |
63
| – | – | ﹤0.01% | 3841 |
|
|
2021
Q3 | $1K | Sell |
63
-128
| -67% | -$2.03K | ﹤0.01% | 3922 |
|
|
2021
Q2 | $4K | Buy |
191
+77
| +68% | +$1.61K | ﹤0.01% | 3634 |
|
|
2021
Q1 | $2K | Buy |
114
+51
| +81% | +$895 | ﹤0.01% | 3655 |
|
|
2020
Q4 | $1K | Buy |
+63
| New | +$1K | ﹤0.01% | 3610 |
|